![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
JM Bathon, DC Manning, DW Goldman, MC Towns and D Proud
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Bradykinin has been implicated in the pathogenesis of inflammatory arthritis by virtue of its potent proinflammatory properties. We have previously shown bradykinin to be a potent stimulus for the release of prostanoids from interleukin-1 (IL-1)-treated, but not untreated, human synovial cells. We hypothesize that one mechanism by which IL-1 induces responsiveness to bradykinin is by upregulation of number or affinity of kinin receptors on human synovial cells. We performed [3H]bradykinin binding studies in intact human synovial tissue and in cultured human synovial cells. Specific, saturable [3H]bradykinin binding sites in intact synovia were identified by autoradiographic localization and were present in much higher density in rheumatoid, than in osteoarthritis, synovia. In untreated human synovial cells in culture, a single (B2) class of kinin binding sites with a Kd of 2.3 nM and Bmax of 58 +/- 9 fmol/10(6) cells was demonstrated. In matched experiments, IL-1 treatment enhanced specific [3H]bradykinin binding 1.5- to 2.0- fold above that observed in untreated cells. This enhancement was attributable to an increase in Bmax (53 +/- 4 vs. 105 +/- 24 fmol/10(6) cells in untreated and IL-1-treated cells, respectively), rather than an alteration in Kd (1.7 and 1.4 nM, respectively). The potencies of a series of kinin analogs and antagonists and unrelated peptides in displacing [3H]bradykinin from IL-1-treated cells correlated well with their abilities to induce prostanoid release. These studies provide novel information regarding the nature of kinin receptors in intact human synovia and in cultured human synovial cells, their regulation by IL-1 and their role in IL-1-treated cells in kinin-mediated prostaglandin E2 production.
This article has been cited by other articles:
|
|
 |
|
  L. M. F. Leeb-Lundberg, F. Marceau, W. Muller-Esterl, D. J. Pettibone, and B. L. Zuraw International Union of Pharmacology. XLV. Classification of the Kinin Receptor Family: from Molecular Mechanisms to Pathophysiological Consequences Pharmacol. Rev., March 1, 2005; 57(1): 27 - 77. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. R. Watkins and S. F. Maier Beyond Neurons: Evidence That Immune and Glial Cells Contribute to Pathological Pain States Physiol Rev, October 1, 2002; 82(4): 981 - 1011. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Böckmann and I. Paegelow Kinins and kinin receptors: importance for the activation of leukocytes J. Leukoc. Biol., November 1, 2000; 68(5): 587 - 592. [Abstract] [Full Text]
|
|
|
|
 |
|
 E.-B. Haddad, A. J. Fox, J. Rousell, G. Burgess, P. McIntyre, P. J. Barnes, and K. F. Chung Post-Transcriptional Regulation of Bradykinin B1 and B2 Receptor Gene Expression in Human Lung Fibroblasts by Tumor Necrosis Factor-alpha : Modulation by Dexamethasone Mol. Pharmacol., June 1, 2000; 57(6): 1123 - 1131. [Abstract] [Full Text]
|
|
|
|
 |
|
 D. A. Walsh, J. Catravas, and J. Wharton Angiotensin converting enzyme in human synovium: increased stromal [125I]351A binding in rheumatoid arthritis Ann Rheum Dis, February 1, 2000; 59(2): 125 - 131. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. Koyama, E. Sato, H. Numanami, K. Kubo, S. Nagai, and T. Izumi Bradykinin Stimulates Lung Fibroblasts to Release Neutrophil and Monocyte Chemotactic Activity Am. J. Respir. Cell Mol. Biol., January 1, 2000; 22(1): 75 - 84. [Abstract] [Full Text]
|
|
|
|
|
|
F. Marceau, J. F. Hess, and D. R. Bachvarov The B1 Receptors for Kinins Pharmacol. Rev., September 1, 1998; 50(3): 357 - 386. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Schmidlin, D. Scherrer, L. Daeffler, C. Bertrand, Y. Landry, and J.-P. Gies Interleukin-1beta Induces Bradykinin B2 Receptor Gene Expression through a Prostanoid Cyclic AMP-Dependent Pathway in Human Bronchial Smooth Muscle Cells Mol. Pharmacol., June 1, 1998; 53(6): 1009 - 1015. [Abstract] [Full Text]
|
|
 |
 |
 |
|
 |
 |
 |
